We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Moelis & Co
MC
$4.97B
| $918K | ﹤0.01% |
23,845
+4,665
| +24% | +$169K |
|
|
TRUE
1977
DELISTED
TrueCar
TRUE
| $914K | ﹤0.01% |
59,059
+1,296
| +2% | +$18K |
|
|
NRE
1978
DELISTED
NorthStar Realty Europe Corp.
NRE
| $914K | ﹤0.01% |
78,852
+4,895
| +7% | +$59.2K |
|
|
XOXO
1979
DELISTED
Xo Group Inc
XOXO
| $908K | ﹤0.01% |
52,775
+13,564
| +35% | +$248K |
|
|
CCRN
1980
DELISTED
Cross Country Healthcare
CCRN
| $907K | ﹤0.01% |
63,172
+17,988
| +40% | +$265K |
|
1981
Alaunos Therapeutics
TCRT
$4.59M
| $907K | ﹤0.01% |
954
+33
| +4% | +$30.7K |
|
1982
Quad
QUAD
$536M
| $901K | ﹤0.01% |
35,706
+965
| +3% | +$24.7K |
|
|
CCF
1983
DELISTED
Chase Corporation
CCF
| $900K | ﹤0.01% |
9,431
+275
| +3% | +$24.8K |
|
|
CACQ
1984
DELISTED
Caesars Acquisition Company
CACQ
| $899K | ﹤0.01% |
58,392
+2,566
| +5% | +$37.5K |
|
1985
Scorpio Tankers
STNG
$3.87B
| $892K | ﹤0.01% |
20,086
+693
| +4% | +$28.9K |
|
|
TMHC
1986
DELISTED
Taylor Morrison
TMHC
| $892K | ﹤0.01% |
41,825
+9,205
| +28% | +$186K |
|
1987
Heritage Financial
HFWA
$1.22B
| $891K | ﹤0.01% |
36,002
+1,216
| +3% | +$30.5K |
|
|
LION
1988
DELISTED
Fidelity Southern Corporation
LION
| $891K | ﹤0.01% |
39,803
+11,840
| +42% | +$275K |
|
1989
Regis Corp
RGS
$68.4M
| $889K | ﹤0.01% |
3,793
+872
| +30% | +$227K |
|
1990
Karyopharm Therapeutics
KPTI
$43.5M
| $883K | ﹤0.01% |
4,586
+266
| +6% | +$42.7K |
|
|
PHH
1991
DELISTED
PHH Corporation
PHH
| $880K | ﹤0.01% |
69,121
+1,136
| +2% | +$15.4K |
|
1992
TriCo Bancshares
TCBK
$1.84B
| $879K | ﹤0.01% |
24,752
+850
| +4% | +$30.2K |
|
|
DHIL
1993
DELISTED
Diamond Hill
DHIL
| $871K | ﹤0.01% |
4,478
+203
| +5% | +$40.6K |
|
1994
Extreme Networks
EXTR
$3.94B
| $869K | ﹤0.01% |
115,765
+4,743
| +4% | +$28.4K |
|
1995
Ezcorp Inc
EZPW
$1.83B
| $861K | ﹤0.01% |
105,659
+26,935
| +34% | +$247K |
|
1996
UNIFI
UFI
$119M
| $858K | ﹤0.01% |
30,226
+8,562
| +40% | +$245K |
|
1997
Box
BOX
$4.37B
| $854K | ﹤0.01% |
52,377
+1,401
| +3% | +$23.7K |
|
|
XLRN
1998
DELISTED
Acceleron Pharma
XLRN
| $854K | ﹤0.01% |
32,272
+1,284
| +4% | +$33.8K |
|
|
BKMU
1999
DELISTED
Bank Mutual Corp
BKMU
| $853K | ﹤0.01% |
90,709
+23,289
| +35% | +$225K |
|
|
NMBL
2000
DELISTED
Nimble Storage, Inc.
NMBL
| $849K | ﹤0.01% |
67,944
+2,597
| +4% | +$25.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.